Subscribe to Search results

Dr Martin's treatment of Stephen was not atypical, it was also practiced where his brother was treated with commercial concentrates from the age of two

Published on:

The second report relating to Stephen's treatment, prepared by Dr Ludlam, noted if cryoprecipitate was not available, then NHS concentrate would be the most appropriate therapy and queried Royal Liverpool Hospital policy

Published on:

Dr Martin said that his treatment of the child with concentrate was consistent with the standard treatment being given to patients at the time

Published on:

Dr Martin described how there was no instruction to use cryoprecipitate on milder haemophiliacs and that it was generally phased out in the early 1980s.

Published on:

Dr Martin did not regard the risk of hepatitis as reason to alter any treatment regime. His aim was however to "keep children out of hospital as much as possible"

Published on:

Dr Martin had no recollection of the 24 June 1983 letter from Professor Bloom and Dr Rizza but accepted that there was no alteration in the treatment regime at the time.

Published on:

Dr Martin did not attend any UKHCDO meetings in the 1970s and 1980s by his own choice.

Published on:

Dr Martin regarded DDAVP of limited value and difficult to use with small children. He made a conscious decision not to use it despite its availability within his hospital.

Published on:

Dr Martin did "not make it [his] practice to raise the hepatitis issue with families" and similarly, did not "wish to worry parents with what at first seemed to be a tenuous link" regarding AIDS.

Published on:

A medical report on a child born in 1981, with moderate haemophilia, shows that he was treated with concentrates from the age of one and received treatment with concentrates on four occasions in 1983. The report from Dr Ludlam outlined that to justify the use of commercial factor VIII concentrate for this child it would have been necessary for Dr Martin to demonstrate several steps were taken to attempt to treat the child with cryoprecipitate

Published on:

A report from the solicitors representing the defendant health authority in the litigation recorded they were "unable" to show that cryoprecipitate and NHS Factor 8 concentrate were not available. Dr Martin "says that he gave no consideration to alternative treatment."

Published on:

Minutes of the ninth meeting of UK Haemophilia Centre Directors' Hepatitis Working Party where Dr Craske presented preliminary data of results from a 4 year surveillance of Factor VIII and IX associated hepatitis, it was recorded that an application had been made to the MRC with a view to a prospective study of patients with mild defects undergoing treatment requiring concentrate cover.

Published on:

Supposedly hepatitis-free concentrate was discussed at the twelfth meeting of the Haemophilia Reference Centre Directors. Dr Kernoff stated that this should be used if it were to be introduced into the UK and that the matter should be referred to the Hepatitis Working Party for consideration and recommendation.

Published on:

Minutes of the twelfth meeting of the Haemophilia Centre Directors where they received Dr Craske's report on behalf of the Hepatitis Working Party for 1980-81 with its recommendations that surveillance and further studies should continue.

Published on:

Haemophilia Centre Directors Hepatitis Working Party Report For Years 1980-81 was published

Published on:

Annual Returns for the Newcastle Haemophilia Centre were produced for 1980.

Published on:

Annual Returns for the Newcastle Haemophilia Centre were produced for 1981.

Published on:

Annual Returns for the Newcastle Haemophilia Centre were produced for 1982.

Published on:

Annual Returns for The Royal Free Hospital Haemophilia Centre were produced for 1980.

Published on:

Annual Returns for The Royal Free Hospital Haemophilia Centre were produced for 1981.

Published on: